<sup>18</sup>F-FDG Pet Parameters and Radiomics Features Analysis in Advanced Nsclc Treated with Immunotherapy as Predictors of Therapy Response and Survival
Objectives: (1.1) to evaluate the association between baseline 18F-FDG PET/CT semi-quantitative parameters of the primary lesion with progression free survival (PFS), overall survival (OS) and response to immunotherapy, in advanced non-small cell lung carcinoma (NSCLC) patients eligible for immunoth...
Main Authors: | Giulia Polverari, Francesco Ceci, Valentina Bertaglia, Maria Lucia Reale, Osvaldo Rampado, Elena Gallio, Roberto Passera, Virginia Liberini, Paola Scapoli, Vincenzo Arena, Manuela Racca, Andrea Veltri, Silvia Novello, Désirée Deandreis |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/5/1163 |
Similar Items
-
Predictive Value of Baseline [18F]FDG PET/CT for Response to Systemic Therapy in Patients with Advanced Melanoma
by: Virginia Liberini, et al.
Published: (2021-10-01) -
NSCLC Biomarkers to Predict Response to Immunotherapy with Checkpoint Inhibitors (ICI): From the Cells to In Vivo Images
by: Virginia Liberini, et al.
Published: (2021-09-01) -
Platelet Induced Functional Alteration of CD4<sup>+</sup> and CD8<sup>+</sup> T Cells in HNSCC
by: Christina Polasky, et al.
Published: (2020-10-01) -
Radiomics of Tumor Heterogeneity in <sup>18</sup>F-FDG-PET-CT for Predicting Response to Immune Checkpoint Inhibition in Therapy-Naïve Patients with Advanced Non-Small-Cell Lung Cancer
by: David Ventura, et al.
Published: (2023-04-01) -
<sup>99m</sup>Tc-Labeled Cyclic Peptide Targeting PD-L1 as a Novel Nuclear Imaging Probe
by: Guillermina Ferro-Flores, et al.
Published: (2023-11-01)